Key result
Resident and monocyte-derived cardiac macrophages link immunometabolism to HFpEF pathogenesis and offer subset-specific therapeutic targets.
Why the study?
Targeting specific macrophage subsets offers promising therapeutic avenues in HFpEF, but challenges like off-target effects and clinical translation remain.
Design
Review
Authors
Loading...
Immunometabolic targeting of macrophage subsets merits exploration in HFpEF; hypothesis-generating and requires prospective trials before clinical adoption.
This review elucidates the immunometabolic crosstalk and distinct roles of macrophage subsets in HFpEF, highlighting emerging subset-specific therapeutic strategies.
Liang et al. (2026) conducted a review in Heart failure with preserved ejection fraction (HFpEF). Cardiac resident macrophages and monocyte-derived macrophages play central roles in linking immunometabolism to HFpEF pathogenesis, offering promising subset-specific therapeutic avenues.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: